Antibody-based therapies are used to treat numerous diseases, from cancer to rheumatic disorders and multiple sclerosis.

The genome differs from person to person in thousands of positions. In some cases, this means that proteins have a different ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies When using antibodies in research or ...

Designation underscores the potential of SAFEbody®-enabled anti-CTLA-4 therapy to address unmet need in MSS colorectal ...

MOG Antibody-associated Disease (MOGAD) is a rare autoimmune disease of the central nervous system. The blood of patients ...

Antibodies have evolved by nature to possess exquisite selectivity for foreign targets to elicit an effective immune response, making particularly promising strides in advancing drug development for ...

Researchers at Texas Biologics at The University of Texas at Austin, working with scientists internationally, have made an ...

Results support the potential of PMN310 to improve outcomes by selectively targeting oligomers and avoiding binding to monomer and plaque . ProMIS on track to complete enrollment ...

Researchers are striving to understand the impact a phenomenon known as original antigenic sin has on immunity to the virus.

The two investment firms were joined by more than a half dozen other backers. The consortium included OpenAI Group PBC and ...

In 2020, as scientists around the world were racing to understand COVID-19, Prof. Roy Bar-Ziv and his team at the Weizmann ...